Brief: Diamyd Medical Patent To Be Granted In China

Diamyd Medical AB

18/01/2022 09:04

Jan 18 (Reuters) - 
    * DIAMYD MEDICAL PATENT FOR INTRALYMPHATIC INJECTION OF GAD
IN
AUTOIMMUNE DIABETES TO BE GRANTED IN CHINA
    * PATENT THAT WILL BE GRANTED BY CHINESE PATENT OFFICE IS
VALID
UNTIL 2035
    * PATENT PRIMARILY PROTECTS ADMINISTRATION METHOD OF
DIAMYD(®)
(GAD/ALUM) WHICH HAS SHOWN POSITIVE RESULTS IN PHASE I/II AND
PHASE IIB TRIALS DIAGNODE-1 AND DIAGNODE-2 AND WILL BE EVALUATED
IN PHASE III TRIAL DIAGNODE-3.

Source text for Eikon:  ID:nWkr4KFZ1H 
Further company coverage: [ ]

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))